The PEGS Boston Summit is where the future of biologics takes shape. For over 20 years, PEGS is the go-to event for protein and antibody engineering, drug development, immunotherapy, radiotherapy, and AI/ML-driven biologics research. New in 2026: a dedicated focus on peptides, spotlighting their therapeutic power, design innovations, and expanding role in drug discovery.
Drop by booth 4257 to see us at the San Diego Convention Center during the American Association of Cancer Research (AACR) Annual Meeting.
AACR’s Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; this meeting highlights the work of the best minds in cancer research from institutions all over the world.
Immerse yourself in possibility at the 2026 ASBMB Annual Meeting in National Harbor, D.C. Metro Area. Discover connections that redefine collaboration, spark breakthroughs that push boundaries, and uncover insights that have the power to shape the future of your field — and the world.
Quantum-Si’s Head of Scientific Affairs, Meredith Carpenter, PhD, will be in Orlando for AGBT’s 2026 General Meeting. She will be presenting her poster, titled “High-Resolutions Detection of Post-Translational Modifications Using Single-Molecule Protein Sequencing”.
US HUPO 2026 in St. Louis Missouri, will feature a full program of outstanding plenary speakers, a great variety of scientific sessions with oral presentations, as well as educational short courses and topic-specific evening workshops.
Stop by QSI Booth #10 and chat about your projects or take in one of the talks (Dave Sloan or Gloria Sheynkman) featuring data generated by QSI technology and highlighting its use as a complimentary technique to mass spec.
Join our own John Kudolo, PhD for a presentation on Advancing Biologics Development With Next-gen protein sequencing.
This Congress is a milestone in our field, bringing together leading minds to discuss how proteomics is revolutionizing our understanding of health across human, animal, plants, and environmental dimensions. We are excited for the rich exchange of ideas, the cutting-edge research, and the opportunity to connect with peers from around the globe.
The American Society of Human Genetics envisions a future where people everywhere realize the benefits of human genetics and genomics research. We work to advance human genetics and genomics in science, health, and society through excellence in research, education, and advocacy.
Come see us at Booth 1128 to understand how proteomics can enhance your genomics research.
Our Biologics US Congress featuring the Proteins & Antibodies and ADC Discovery & Development programs, sets out to answer this question – over 6 tracks, uncover the next generation of biologics research, from novel engineering strategies to enhance antibody function & AI-driven antibody design to optimizing ADCs and utilizing these beyond just oncology. This revamped program will be packed with interactivity, networking opportunities and exclusive talks to equip you with the knowledge and connections needed to inform your pipeline and ensure the success of your R&D.
The symposium will focus on top-down proteomics, the analysis of intact proteins and protein complexes using high-resolution mass spectrometry. Top-down proteomics is an emerging technology that offers an unprecedented level of accuracy in the detection of differentially modified intact proteins (proteoforms) or associated complexes.